- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Tianjin Medical University Cancer Institute and Hospital
I alt 3813 resultater
-
Institute of Hematology & Blood Diseases Hospital...Henan Cancer Hospital; Beijing Children's Hospital; Tianjin Medical University... og andre samarbejdspartnereRekrutteringPrimær immun trombocytopeni (ITP)Kina
-
St. Joseph's Hospital and Medical Center, PhoenixNational Cancer Institute (NCI)RekrutteringHjerne svulstForenede Stater
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; 307 Hospital of PLA; Qilu Hospital of Shandong... og andre samarbejdspartnereUkendtEkstranodal naturlig dræber/T-cellelymfom, næsetypeKina
-
Wanqi ZhangThe Shandong Institute for Endemic Disease Control and ResearchAfsluttet
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Tongji Hospital; Qilu Hospital... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
Cancer Institute and Hospital, Chinese Academy...Fujian Cancer HospitalRekruttering
-
Cancer Institute and Hospital, Chinese Academy...Peking University First Hospital; Cancer Institute and Hospital, Chinese...Rekruttering
-
Capital Medical UniversityCancer Institute and Hospital, Chinese Academy of Medical SciencesSuspenderet
-
Cancer Institute and Hospital, Chinese Academy...Zhejiang Cancer Hospital; Sun Yat-sen University; Henan Cancer Hospital; Tongji... og andre samarbejdspartnereUkendt
-
Beijing Children's HospitalChildren's Hospital of Hebei Province; Tianjin Children's Hospital; Capital... og andre samarbejdspartnereUkendt
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; Affiliated Cancer Hospital... og andre samarbejdspartnereRekrutteringTidlig stadie | Ekstranodal NK-T-cellelymfom, nasal og nasal-typeKina
-
Peking University First HospitalThe Forth Medical Center of PLA General Hospital; Tianjin Orthopedic HospitalRekrutteringFejlernæring | Hoftebrud | Ældre patienter | Overlevelse | Perioperative resultater | ErnæringsinterventionKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Kemoterapi | Immunterapi | Kemoradioterapi | NimotuzumabKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEndometriekarcinom | Tilbagevendende eller metastatisk | TP53 mutationKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuTrippel-negativ brystkræft i tidligt stadium med BRCA1/2-mutationerKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuLipider | Ung brystkræftpatient | Anti-tumor lægemiddelterapi
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAdenocarcinom i bugspytkirtlen | Avanceret kræft | Stofbrug | Capecitabin | Oxaliplatin | Første linje | Cadonilimab | Nanoliposomal irinotecanKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuBugspytkirtelkræft
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHepatocellulært karcinom | Strålebehandling | Tislelizumab | Tumor tromboseKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuIkke småcellet lungekræft | ERBB2 mutationsrelaterede tumorer | Disitamab Vedotin | ERBB2 genduplikering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlanocellulært karcinom i hoved og halsKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlanocellulært karcinom i hoved og halsKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt tilbagevendende tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMålrettet terapi | HR+/HER2- Avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret lungekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystkræft | Kemoterapi effektKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringNasopharyngealt karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPatienter med avancerede solide tumorerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSarkom, blødt væv | Bagagerum | Ekstremitet | Intensitetsmoduleret strålebehandling | Større sårkomplikationer | Målrettet terapiKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHormonreceptor positiv avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuRefraktær lymfom | DLBCL | MYD88 genmutation | Tilbagefald | CD79A genmutation | CD79B genmutation
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuHepatocellulært karcinom resektabelt
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEsophageal pladecellekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Kemoradiation | Kirurgi | Kemoterapi effekt | Immunterapi | Målrettet terapi | Esophagogastric Juction CancerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt avanceret ikke-småcellet lungekræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret hepatocellulært karcinom | Strålebehandling | Sorafenib | ToripalimabKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringUbehandlede avancerede NSCLC-patienter | FISH Identificeret ALK Fusion Positiv eller NegativKina